AORT

SEC source: 0001628280-26-061602 · wk-form4_1789162125.xml · nonDerivative · entry 1

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,160

F1 · price: Reflects weighted average price. Range of prices were between $24.840 to $25.235. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-060667 · wk-form4_1788545710.xml · nonDerivative · entry 2

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,640

F2 · price: Reflects weighted average price. Range of prices were between $26.000 to $26.040. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-060667 · wk-form4_1788545710.xml · nonDerivative · entry 1

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,133

F1 · price: Reflects weighted average price. Range of prices were between $27.000 to $27.760. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-058212 · wk-form4_1787249462.xml · nonDerivative · entry 1

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 877,275

F1 · price: Reflects weighted average price. Range of prices were between $28.89 to $29.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-057330 · wk-form4_1786994326.xml · nonDerivative · entry 1

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,643

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-057327 · wk-form4_1786994249.xml · nonDerivative · entry 1

Berry Lance A · CIK 0001478716 · EVP, COO, CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,112

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-056381 · wk-form4_1786571504.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,118

F1 · price: Reflects the price the shares were sold.

SEC source: 0001628280-26-043059 · wk-form4_1781537334.xml · derivative · entry 6

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2029-11-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.

F5 · derivative.exercise_date: Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

SEC source: 0001628280-26-043059 · wk-form4_1781537334.xml · derivative · entry 5

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,001 shares

Expires 2029-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.

F4 · derivative.exercise_date: Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023.

SEC source: 0001628280-26-043059 · wk-form4_1781537334.xml · nonDerivative · entry 4

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,259

F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.

F3 · price: Reflects weighted average price. Range of prices were between $20.24 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-043059 · wk-form4_1781537334.xml · nonDerivative · entry 3

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.

SEC source: 0001628280-26-043059 · wk-form4_1781537334.xml · nonDerivative · entry 2

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,259

F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.

F2 · price: Reflects weighted average price. Range of prices were between $20.25 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-043059 · wk-form4_1781537334.xml · nonDerivative · entry 1

GREEN ANDREW M · CIK 0001191000 · SVP, Regulatory and Quality

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,260

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.

SEC source: 0001628280-26-040860 · wk-form4_1780606213.xml · nonDerivative · entry 2

SEMEDO ANTHONY B. · CIK 0001886324 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Stacie Nelson and Anthony Semedo Living Trust

Disclosed balance after: 6,325

F1 · shares: Represents a transfer of shares from the Reporting Person's directly held account to an account held by the Stacie Nelson and Anthony Semedo Living Trust. The transfer was made for estate planning purposes, involved no sale or other disposition for value, and resulted only in a change in the form of beneficial ownership from direct to indirect.

F2 · ownership.nature: The shares of common stock are held of record by the Stacie Nelson and Anthony Semedo Living Trust, a revocable living trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust and may be deemed to beneficially own such shares.

SEC source: 0001628280-26-040860 · wk-form4_1780606213.xml · nonDerivative · entry 1

SEMEDO ANTHONY B. · CIK 0001886324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,635

F1 · shares: Represents a transfer of shares from the Reporting Person's directly held account to an account held by the Stacie Nelson and Anthony Semedo Living Trust. The transfer was made for estate planning purposes, involved no sale or other disposition for value, and resulted only in a change in the form of beneficial ownership from direct to indirect.

SEC source: 0001628280-26-037028 · wk-form4a_1779326110.xml · nonDerivative · entry 1

Borgstrom Marna P · CIK 0001744267 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,664

F1 · date: This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment.

F1 · shares: This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment.

F2 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

F1 · balance_after: This amendment is being filed solely to correct an administrative error in the transaction date, number of shares granted and owned, and vesting date reported in the original Form 4. The restricted stock award was granted on May 18, 2026, rather than May 14, 2026 as previously reported; consisted of 7,576 shares, rather than 7,850 shares as previously reported; will vest on May 18, 2027, rather than May 14, 2027 as previously reported; and the amount of securities beneficially owned is 56,664, rather than 56,938 as previously reported. No other changes are being made by this amendment.

SEC source: 0001628280-26-037008 · wk-form4_1779323838.xml · nonDerivative · entry 1

SEMEDO ANTHONY B. · CIK 0001886324 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,960

F1 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

F2 · balance_after: Mr. Semedo also indirectly owns 600 shares through his spouse.

SEC source: 0001628280-26-037006 · wk-form4_1779323726.xml · nonDerivative · entry 1

Salveson Jon W · CIK 0001372026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,416

F1 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-037004 · wk-form4_1779323634.xml · nonDerivative · entry 1

Hoff Elizabeth A · CIK 0001949762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,765

F1 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-037001 · wk-form4_1779323520.xml · nonDerivative · entry 1

Burbank Jeffrey H · CIK 0001341411 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,372

F1 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-036999 · wk-form4_1779323410.xml · nonDerivative · entry 1

Bullock James · CIK 0001172340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,223

F1 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-036997 · wk-form4_1779323304.xml · nonDerivative · entry 1

BEVEVINO DANIEL J · CIK 0001186458 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,637

F1 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-036995 · wk-form4_1779323164.xml · nonDerivative · entry 1

ACKERMAN THOMAS F · CIK 0001141720 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,472

F1 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-036713 · wk-form4_1779242386.xml · nonDerivative · entry 1

Borgstrom Marna P · CIK 0001744267 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,938

F1 · shares: RSA Grant vests on May 14, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-014896 · wk-form4_1772668382.xml · nonDerivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,095

F3 · price: Reflects the price the shares were sold.

SEC source: 0001628280-26-014898 · wk-form4_1772668477.xml · nonDerivative · entry 2

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,088

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-014896 · wk-form4_1772668382.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,057

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-014894 · wk-form4_1772668260.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,097

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-014892 · wk-form4_1772668162.xml · nonDerivative · entry 2

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,794

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-014890 · wk-form4_1772668063.xml · nonDerivative · entry 2

Berry Lance A · CIK 0001478716 · EVP, COO, CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,827

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-014887 · wk-form4_1772667862.xml · nonDerivative · entry 2

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 947,275

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-013724 · wk-form4_1772569510.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,514

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-013690 · wk-form4_1772568267.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,408

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-013684 · wk-form4_1772568129.xml · nonDerivative · entry 1

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 848,214

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-013682 · wk-form4_1772568014.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,105

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-013676 · wk-form4_1772567508.xml · nonDerivative · entry 1

Berry Lance A · CIK 0001478716 · EVP, COO, CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,269

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-013672 · wk-form4_1772567369.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,522

F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-014898 · wk-form4_1772668477.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,989

F1 · shares: Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.

SEC source: 0001628280-26-014896 · wk-form4_1772668382.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,900

F1 · shares: Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.

SEC source: 0001628280-26-014894 · wk-form4_1772668260.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,246

F1 · shares: Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.

SEC source: 0001628280-26-014892 · wk-form4_1772668162.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,367

F1 · shares: Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.

SEC source: 0001628280-26-014890 · wk-form4_1772668063.xml · nonDerivative · entry 1

Berry Lance A · CIK 0001478716 · EVP, COO, CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,143

F1 · shares: Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.

SEC source: 0001628280-26-014887 · wk-form4_1772667862.xml · nonDerivative · entry 1

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 965,162

F1 · shares: Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.

SEC source: 0001628280-26-011843 · wk-form4_1772059387.xml · nonDerivative · entry 3

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,155

F3 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-011843 · wk-form4_1772059387.xml · nonDerivative · entry 2

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,497

F2 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-011837 · wk-form4_1772058983.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,921

F2 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-011833 · wk-form4_1772058946.xml · nonDerivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,288

F3 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-011833 · wk-form4_1772058946.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,203

F2 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

SEC source: 0001628280-26-011831 · wk-form4_1772058879.xml · nonDerivative · entry 3

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 863,125

F3 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

SEC source: 0001628280-26-011831 · wk-form4_1772058879.xml · nonDerivative · entry 2

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 766,095

F2 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.